Investigation of Metabolomics Differences Between Metabolic Syndrome and Healthy Individuals in Taiwan

The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.

NCT Number	NCT06363864
Lead Sponsor	Leeuwenhoek Laboratories Co. Ltd.
Conditions	Metabolic Syndrome
Enrollment	1,200 participants
Start Date	2024-04-14
Primary Completion	2029-10-31 (estimated)
Study Completion	2029-10-31 (estimated)
Updated on ClinicalTrials.gov	2024-04-12